LONDON, UK - Media OutReach - 11 March 2019 - Vindobonum FinanceB.V. (the "Issuer") and Ceviz SırtıGayrimenkul Yatırımcılığı İnşaat Taahhüt Turizm A.Ş. as part of CapitalPartners Ltd., and together with its fully consolidated subsidiaries (the "Group"), has mandated BMI InternationalEurope Limited as Sole Placement Agent to arrange a series of fixed incomeinvestor meetings in Hong Kong, Singapore, Vienna, Zurich, Geneva and London,commencing on 12 March 2019.
Theroad show will start in Hong Kong on the 12th and Singapore on 14th,followed by the European part in Vienna on the 18th, in Zurich on 19th,Geneva on 20th, and finishing in London on 21st-22nd.
Aproposed Regulation S only offering of Euro-denominated fixed rate guaranteedand secured notes (the "Notes") ofthe Issuer may follow, subject to market conditions and investors' interest.
MANUFACTURER TARGET MARKET (MIFID II PRODUCTGOVERNANCE) IS ELIGIBLE COUNTERPARTIES AND PROFESSIONAL CLIENTS ONLY (ALLDISTRIBUTION CHANNELS). NO PRIIPS KEY INFORMATION DOCUMENT (KID) HAS BEENPREPARED AS NOT AVAILABLE TO RETAIL IN EEA.
Noprospectus has been or will be approved and/or published pursuant to theDirective 2003/71/EC of the European Parliament and of the Council of 4November 2003 on the prospectus to be published when securities are offered tothe public or admitted to trading and amending Directive 2001/34/EC as amended(the "Prospectus Directive").Neither this announcement nor any other announcement connected therewith may bedistributed, passed on or disclosed to any other person in the EuropeanEconomic Area, save as specifically agreed with BMI International EuropeLimited. BMI International Europe Limited has represented and agreed that itwill offer the Notes in the European Economic Area only in compliance with theprovisions of the Prospectus Directive and all other laws and regulations inthe European Economic Area applicable to the offer and the sale of the Notes inthe European Economic Area.
NOT FOR DISTRIBUTION, DIRECTLY ORINDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR IN ANYOTHER JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION WOULD BEPROHIBITED BY APPLICABLE LAW